FI870448A0 - Antihistaminkompositioner, som innehaoller n-heterocyklyl-4-piperidinaminer. - Google Patents

Antihistaminkompositioner, som innehaoller n-heterocyklyl-4-piperidinaminer.

Info

Publication number
FI870448A0
FI870448A0 FI870448A FI870448A FI870448A0 FI 870448 A0 FI870448 A0 FI 870448A0 FI 870448 A FI870448 A FI 870448A FI 870448 A FI870448 A FI 870448A FI 870448 A0 FI870448 A0 FI 870448A0
Authority
FI
Finland
Prior art keywords
alkyl
substd
alkoxy
furanyl
opt
Prior art date
Application number
FI870448A
Other languages
English (en)
Other versions
FI870448A (fi
Inventor
Frans Eduard Janssens
Jozef Francis Hens
Joseph Leo Ghislanus Torremans
Jozef Jan Pieter Heykants
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI870448A0 publication Critical patent/FI870448A0/fi
Publication of FI870448A publication Critical patent/FI870448A/fi
Priority to FI904082A priority Critical patent/FI904082A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI870448A 1986-02-03 1987-02-02 Antihistaminkompositioner, som innehaoller n-heterocyklyl-4-piperidinaminer. FI870448A (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI904082A FI904082A0 (fi) 1986-02-03 1990-08-17 Foerfarande foer framstaellning av n-heterocyklyl-4-piperidinaminer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82549186A 1986-02-03 1986-02-03

Publications (2)

Publication Number Publication Date
FI870448A0 true FI870448A0 (fi) 1987-02-02
FI870448A FI870448A (fi) 1987-08-04

Family

ID=25244134

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870448A FI870448A (fi) 1986-02-03 1987-02-02 Antihistaminkompositioner, som innehaoller n-heterocyklyl-4-piperidinaminer.

Country Status (26)

Country Link
EP (1) EP0232937B1 (fi)
JP (2) JPH0794393B2 (fi)
CN (1) CN1018614B (fi)
AT (1) ATE79620T1 (fi)
AU (1) AU583706B2 (fi)
CA (1) CA1327579C (fi)
CY (1) CY1865A (fi)
DE (1) DE3781173T2 (fi)
DK (1) DK173674B1 (fi)
EG (1) EG17993A (fi)
ES (1) ES2052544T3 (fi)
FI (1) FI870448A (fi)
GR (1) GR3006158T3 (fi)
HK (1) HK114695A (fi)
HU (1) HU201067B (fi)
IE (1) IE60885B1 (fi)
IL (1) IL81448A (fi)
MA (1) MA20868A1 (fi)
NO (1) NO870407L (fi)
NZ (1) NZ219165A (fi)
PH (1) PH24738A (fi)
PT (1) PT84234B (fi)
TN (1) TNSN87015A1 (fi)
ZA (1) ZA87744B (fi)
ZM (1) ZM1287A1 (fi)
ZW (1) ZW2087A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
US4988689A (en) * 1987-07-01 1991-01-29 Janssen Pharmaceutica N.V. ((Pharmacologically active bicyclic heterocyclic)methyl and -heteroatom) substituted hexahydro-1H-azepines and pyrrolidines
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
IT1229231B (it) * 1989-05-08 1991-07-26 Dompe Farmaceutici Spa Aminoimidazopiridine farmacologicamente attive
CA2043564A1 (en) * 1990-07-06 1992-01-07 Alfons G. M. De Knaep 3-[(5-methyl-2-furanyl)methyl]-n-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
AU730229B2 (en) * 1992-09-03 2001-03-01 Sepracor, Inc. Use of norastemizole for the treatment of allergic disorders
CA2143610C (en) * 1992-09-03 2004-08-24 Raymond L. Woosley Use of norastemizole for the treatment of allergic disorders
US5624948A (en) * 1993-05-20 1997-04-29 Kissei Pharmaceutical Co., Ltd. 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds
TW429256B (en) * 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
NZ527200A (en) * 1997-03-26 2004-12-24 Sepracor Inc Stable norastemizole formulations including a super disintegrant
US5817823A (en) * 1997-04-17 1998-10-06 Sepracor Inc. Method for synthesizing 2-substituted imidazoles
AP1552A (en) 1999-06-28 2006-01-17 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors.
ATE258928T1 (de) 1999-06-28 2004-02-15 Janssen Pharmaceutica Nv Respiratorisches syncytialvirus replikation inhibitoren
DE60033859T2 (de) * 1999-06-28 2007-11-08 Janssen Pharmaceutica N.V. Hemmer des Respiratorischen Syncytial Virus
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
US20070021404A1 (en) * 2003-06-24 2007-01-25 Dan Peters Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1706403B9 (en) 2003-12-22 2012-07-25 K.U.Leuven Research & Development Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
SI1841765T1 (sl) 2004-12-21 2009-08-31 Gilead Sciences Inc Imidazo(4,5-c)piridinska spojina in postopek za antivirusno zdravljenje
JP5065908B2 (ja) * 2004-12-24 2012-11-07 プロシディオン・リミテッド Ｇタンパク質結合受容体作動薬
JP5078869B2 (ja) 2005-03-08 2012-11-21 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ニューロキニン（ｎｋ１）拮抗物質としてのジアザ−スピロ−［４．４］−ノナン誘導体
PL2038275T3 (pl) 2006-07-07 2010-08-31 Gilead Sciences Inc Nowe pochodne pirydazyny i ich zastosowanie
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
AU2009296820B2 (en) * 2008-09-26 2014-03-20 Merck Sharp & Dohme Llc Novel cyclic benzimidazole derivatives useful anti-diabetic agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
IN156065B (fi) * 1982-07-12 1985-05-04 Janssen Pharmaceutica Nv
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
PL144514B1 (en) * 1984-01-09 1988-06-30 Janssen Pharmaceutica Nv Method of obtaining novel derivatives of n-/4-piperidinolo/-2-imidazoloamine
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives

Also Published As

Publication number Publication date
AU6821887A (en) 1987-08-06
ZM1287A1 (en) 1988-08-29
DK173674B1 (da) 2001-06-05
JPH0794393B2 (ja) 1995-10-11
EP0232937A3 (en) 1988-04-06
JPH07179458A (ja) 1995-07-18
PT84234A (en) 1987-03-01
ZA87744B (en) 1988-10-26
CA1327579C (en) 1994-03-08
DK54187A (da) 1987-08-04
ES2052544T3 (es) 1994-07-16
NZ219165A (en) 1990-04-26
AU583706B2 (en) 1989-05-04
DE3781173T2 (de) 1992-12-17
NO870407L (no) 1987-08-04
PH24738A (en) 1990-10-01
CN1018614B (zh) 1992-10-14
DE3781173D1 (de) 1992-09-24
IE870258L (en) 1987-08-03
NO870407D0 (no) 1987-02-02
DK54187D0 (da) 1987-02-02
FI870448A (fi) 1987-08-04
HU201067B (en) 1990-09-28
JPS62215575A (ja) 1987-09-22
IE60885B1 (en) 1994-08-24
EP0232937B1 (en) 1992-08-19
EG17993A (en) 1991-08-30
TNSN87015A1 (fr) 1990-01-01
EP0232937A2 (en) 1987-08-19
PT84234B (pt) 1989-09-14
MA20868A1 (fr) 1987-10-01
IL81448A (en) 1990-09-17
GR3006158T3 (fi) 1993-06-21
CY1865A (en) 1996-04-05
ZW2087A1 (en) 1988-08-31
ATE79620T1 (de) 1992-09-15
HUT44544A (en) 1988-03-28
JPH0819126B2 (ja) 1996-02-28
CN87100563A (zh) 1987-08-19
IL81448A0 (en) 1987-09-16
HK114695A (en) 1995-07-21

Similar Documents

Publication Publication Date Title
FI870448A (fi) Antihistaminkompositioner, som innehaoller n-heterocyklyl-4-piperidinaminer.
RU94019971A (ru) Производные 1,3-дигидро-2н-имидазо /4,5-в/хинолин-2-она в качестве ингибиторов, фосфодиэстеразы, способ их получения, промежуточные для них, фармацевтическая композиция и способ ее получения
DE60123277D1 (de) Makrolidantibiotika
CA2498143A1 (en) Antimicrobial composition and method for use
UY25459A1 (es) Procedimiento para preparar una forma cristalina del acido 7 -([1a, 5a, 6a]-6-amino-3-azabiciclo [3, 1, 0] hex-3-il)-6-fl uor-1-(2,4-difluorofenil)-1, 4-dihidro-4-oxo-1, 8-naftiridin -3-carboxilico anhidro, sal del acido metanosulfonico
SE0002476D0 (sv) New compounds
NO912414D0 (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
ATE342266T1 (de) 1-methylcarbapenemderivate
NO932722L (no) Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon
UY26459A1 (es) 3,4-dihidroquinazolinas 5,6-disustituidas
FI872930A0 (fi) Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi
RU2003104017A (ru) Ингибиторы тромбина, содержащие аминоизохинолиновую группу
RU2021128535A (ru) Синергетическая композиция, содержащая четвертичное аммониевое соединение и карнозиновую кислоту для применения в качестве антибактериального, антигрибкового средства
SE0301904D0 (sv) Novel imidazopyridine compound II with therapeutic effect
WO2023154804A3 (en) Method of treating spinal cord injury and composition for use therein
DE69103068T2 (de) Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.
PT728001E (pt) Utilizacao de derivados de 2-amino-purina para o tratamento e profilaxia das infeccoes pelo virus de herpes humano.
RU2002108719A (ru) Лекарственное средство для профилактики и терапии офтальмологических заболеваний
TH58970B (th) สูตรผสมสำหรับใช้กับตา

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: JANSSEN PHARMACEUTICA N.V.